You are here

Hepatitis C in EECA
Year: 
2016
Go to Website

Hepatitis C in Eastern Europe and Central Asia. Civil Society Response to the Epidemic

by
Alliance for Public Health

The purpose of this report is to provide an overview of key aspects of the hepatitis C (HCV) epidemic and response in Eastern Europe and Central Asia (EECA). It also outlines tools and activities for civil society organizations (CSOs) and community-based groups working on expanding access to HCV treatment in the region. Right now, there is a strong global movement towards elimination of the HCV epidemic. It is essential that this analysis is available to ensure that the EECA region is not left out of global strategies being developed to provide universal access to innovative curative treatment regimens currently in the pipeline.

The overview summarizes data from 11 EECA countries (Armenia, Azerbaijan, Belarus, Georgia, Kazakhstan, Kyrgyzstan, Moldova, Russia, Tajikistan, Ukraine and Uzbekistan) with a focus on availability of HCV medicines, HCV treatment guidelines, national/donor HCV treatment programs, and civil society involvement in the HCV response. It also offers possible approaches and steps that could be taken by CSOs to improve access to HCV treatmen

  • General public
  • NGOs
  • People living with HIV (PLHIV)
  • People who use drugs (PUD)
  • Central Asia
  • Eastern Europe
  • Advocacy
  • Affordability
  • Co-infections
  • Epidemiology
  • Inequalities in health
  • Laws and regulations
  • Legislation
  • Monitoring and Evaluation
  • Policy
  • Viral hepatitis

Twitter News